Introducing Osimertinib Tablet 80mg, a ground-breaking development in oncology created exclusively to combat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). For those heroically fighting this powerful disease, it represents a ray of hope and provides a useful weapon in the fight for recovery. Patients can enjoy a newfound feeling of optimism as they set out on their path to recovery with every dosage of Osimertinib Tablet 80mg. Osimertinib, the active component in this pill, targets certain genetic abnormalities that fuel the development of cancer cells.
Product details
Strength |
80mg |
Packaging Size |
1*10 Tablet |
Form |
Tablet |
Prescription/Non prescription |
Non Prescription |
Treatment |
LUNG CANCER |
Manufacturer |
Astrazeneca |
Composition |
OSIMERTINIB |
Brand |
Tagrisso 80mg |
DHEER HEALTHCARE PRIVATE LIMITED
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |